glutamine and melphalan

glutamine has been researched along with melphalan in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (40.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (40.00)	29.6817
2010's	2 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Rabinovitz, M; Rabon, A; Vistica, DT	1
Begleiter, A; Goldenberg, GJ; Lam, HY	1
Rabinovitz, M; Toal, JN; Vistica, DT	1
Goldenberg, GJ; Kobrinsky, NL; Miller, L	1
Cockerham, MB; Lerchie, SB; Weinberger, BB	1
Balmaceda, CM; Gooch, CL; Hesdorffer, CS; Stubblefield, MD; Troxel, AB; Vahdat, LT	1
Goto, H; Izaki, S; Yokota, S	1

Reviews

1 review(s) available for glutamine and melphalan

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for glutamine and melphalan

Article	Year
Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study. Clinical oncology (Royal College of Radiologists (Great Britain)), 2005, Volume: 17, Issue:4 Topics: Action Potentials; Administration, Oral; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Electrophysiology; Glutamine; Granulocyte Colony-Stimulating Factor; Humans; Melphalan; Neural Conduction; Neuroprotective Agents; Paclitaxel; Peripheral Nervous System Diseases; Stem Cell Transplantation; Thiotepa	2005

Article

Year

Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study.

Clinical oncology (Royal College of Radiologists (Great Britain)), 2005, Volume: 17, Issue:4

Topics: Action Potentials; Administration, Oral; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Electrophysiology; Glutamine; Granulocyte Colony-Stimulating Factor; Humans; Melphalan; Neural Conduction; Neuroprotective Agents; Paclitaxel; Peripheral Nervous System Diseases; Stem Cell Transplantation; Thiotepa

2005

Other Studies

8 other study(ies) available for glutamine and melphalan

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Enhancement of melphalan therapy with glutaminase:asparaginase. Research communications in chemical pathology and pharmacology, 1978, Volume: 22, Issue:1 Topics: Acinetobacter; Animals; Asparaginase; Asparagine; Drug Synergism; Glutaminase; Glutamine; Leukemia L1210; Melphalan; Mice; Time Factors	1978
Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro. The Journal of biological chemistry, 1979, Feb-25, Volume: 254, Issue:4 Topics: Amino Acids; Biological Transport, Active; Carrier Proteins; Cell Line; Glutamine; Kinetics; Leucine; Melphalan	1979
Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells. Cancer treatment reports, 1976, Volume: 60, Issue:9 Topics: Amino Acids; Animals; Cells, Cultured; Drug Interactions; Drug Resistance; Glutamine; Leucine; Leukemia L1210; Melphalan; Mice; Phenylalanine; Structure-Activity Relationship	1976
Modulation of membrane transport of alkylating agents and amino acids by an analog of vasopressin in murine L5178Y lymphoblasts in vitro. Biochemical pharmacology, 1987, Jan-01, Volume: 36, Issue:1 Topics: Alkylating Agents; Amino Acids; Animals; Cyclophosphamide; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Glutamine; In Vitro Techniques; Kinetics; Leucine; Leukemia L5178; Leukemia, Experimental; Melphalan; Mice	1987
Oral glutamine for the prevention of oral mucositis associated with high-dose paclitaxel and melphalan for autologous bone marrow transplantation. The Annals of pharmacotherapy, 2000, Volume: 34, Issue:3 Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Bone Marrow Transplantation; Breast Neoplasms; Gastrointestinal Diseases; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Middle Aged; Paclitaxel; Retrospective Studies; Suspensions; Transplantation, Autologous	2000
Increased chemosensitivity and elevated reactive oxygen species are mediated by glutathione reduction in glutamine deprived neuroblastoma cells. Journal of cancer research and clinical oncology, 2008, Volume: 134, Issue:7 Topics: Antineoplastic Agents, Alkylating; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Glutamine; Glutathione; Humans; Melphalan; Neuroblastoma; Oxidation-Reduction; Reactive Oxygen Species	2008